Omidenepag Isopropyl Versus Timolol in Patients With Glaucoma or Ocular Hypertension: Two Randomized Phase 3 Trials (SPECTRUM 4 and 3)

Bacharach J., Brubaker J.W., Evans D.G., LU F., Odani-Kawabata N., Yamabe T., Wirta D.L.

2024
American Journal of Ophthalmology

View publication

Therapeutic Area

Glaucoma
Categories

Clinical development

Affiliations

From the North Bay Eye Associates (J.B.), Petaluma, CA, United States; Sacramento Eye Consultants (J.W.B.), Sacramento, CA, United States; Total Eye Care, P.A.(D.G.E.), Memphis, TN, United States; Santen, Inc.(F.L., T.Y.), Emeryville, CA, United States; Santen Pharmaceutical Co., Ltd (N.O.-K., T.Y.), Osaka, Japan; Eye Research Foundation (D.L.W.), Newport Beach, CA, United States

Related Publications

Clinical outcomes of Preserflo MicroShunt implant procedure in open‑angle glaucoma patients – a 1000 eyes case-series; including subanalysis of combined cataract-glaucoma surgery and standalone surgery in pseudophakic eyes

Klabe, K.; Werth, J.P.; Kaymak, H. ; Fricke, A.

Müller glia derived EVs promote neurite recovery of an enriched population of retinal ganglion like cells derived from hESC retinal organoids after damage

Eastlake K, Lamb WDB, Tracey-White D, Shibagaki K, Khaw PT, Jayaram H, Limb GA

An Exploratory Study of Machine Learning-Based Open-Angle Glaucoma Detection Using Specific Autoantibodies

Takada N., Ishikawa M., Ninomiya T., Izumi Y., Sato K., Kunikata H., Yokoyama Y., Tsuda S., Fukuda E., Yamaguchi K., Ono C., Kirihara T., Shintani C., Hanyuda A., Goshima N., Zorumski C.F., NakazawaT.

View all Glaucoma publications